Mining the Swedish clinical archives to develop pharmacogenomic tests

Molecular Diagnosis

Volumn 4, Issue 4, 1999, Pages 319-325

  Sanders, Rhiannon ^a  

^a Eurona Medical AB   (Sweden)

Author keywords

Epidemiology; Genotyping; Health care; Utility

Indexed keywords

DRUG RESPONSE; HYPERTENSION; MEDICAL RESEARCH; PHARMACOGENOMICS; QUALITY CONTROL; REVIEW; SWEDEN;

EID: 0033451971     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-8592(99)80008-3     Document Type: Article

References (5)

1. Housman D, Ledley FD: Why pharmacogenomics? Why now? Nat Biotechnol 1998;16:492-493
2. Marshall A: Laying the foundations for personalized medicines. Nat Biotechnol 1997;15:954-957
3. Adami J, Gridley G, Nyren O, et al.: Sunlight and non-Hodgkin's lymphoma: A population-based cohort study in Sweden. Int J Cancer 1999;80:641-645
4. Lambe M, Hsieh C-C, Tsaih S-W, Ekbom A, Trichopoulos D, Adami H-O: Parity, age at first birth and the risk of carcinoma in situ of the breast. Int J Cancer 1998;77:330-332 .
5. Kilander L, Nyman H, Boberg M, Lithell H: Cognitive function, vascular risk factors and education. A cross-sectional study based on a cohorhof 70-year-old men. J Intern Med 1997;242:313-321